Abstract:Genomic surveillance of viral isolates during the 2013-2016 Ebola virus epidemic in Western Africa, the largest and most devastating filovirus outbreak on record, revealed several novel mutations. The responsible strain, named Makona, carries an A-to-V substitution at position 82 (A82V) in the glycoprotein (GP), which is associated with enhanced infectivity in vitro Here, we investigated the mechanistic basis for this enhancement as well as the interplay between A82V and a T-to-I substitution at residue 544 of GP, which also modulates infectivity in cell culture. We found that both 82V and 544I destabilize GP, with the residue at position 544 impacting overall stability, while 82V specifically destabilizes proteolytically cleaved GP. Both residues also promote faster kinetics of lipid mixing of the viral and host membranes in live cells, individually and in tandem, which correlates with faster times to fusion following colocalization with the viral receptor Niemann-Pick C1 (NPC1). Furthermore, GPs bearing 82V are more sensitive to proteolysis by cathepsin L (CatL), a key host factor for viral entry. Intriguingly, CatL processed 82V variant GPs to a novel product with a molecular weight of approximately 12,000 (12K), which we hypothesize corresponds to a form of GP that is pre-triggered for fusion. We thus propose a model in which 82V promotes more efficient GP processing by CatL, leading to faster viral fusion kinetics and higher levels of infectivity.IMPORTANCE The 2013-2016 outbreak of Ebola virus disease in West Africa demonstrated the potential for previously localized outbreaks to turn into regional, or even global, health emergencies. With over 28,000 cases and 11,000 confirmed deaths, this outbreak was over 50 times as large as any previously recorded. This outbreak also afforded the largest-ever collection of Ebola virus genomic sequence data, allowing new insights into viral transmission and evolution. Viral mutants arising during the outbreak have attracted attention for their potentially altered patterns of infectivity in cell culture, with potential, if unclear, implications for increased viral spread and/or virulence. Here, we report the properties of one such mutation in the viral glycoprotein, A82V, and its interplay with a previously described polymorphism at position 544. We show that mutations at both residues promote infection and fusion activation in cells but that A82V additionally leads to increased infectivity under cathepsin-limited conditions and the generation of a novel glycoprotein cleavage product.

The 2014 Ebola Virus Outbreak in West Africa Highlights No Evidence of Rapid Evolution or Adaptation to Humans

Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak

Epidemiological and evolutionary analysis of the 2014 Ebola virus outbreak

Intra-host Ebola Viral Adaption During Human Infection

Intra-host Dynamics of Ebola Virus During 2014.

Mapping the Clinical Outcomes and Genetic Evolution of Ebola Virus in Sierra Leone.

Naturally Occurring Single Mutations in Ebola Virus Observably Impact Infectivity.

Natural history of Ebola virus disease in rhesus monkeys shows viral variant emergence dynamics and tissue-specific host responses

Virus genomes reveal factors that spread and sustained the Ebola epidemic

Features of Ebola Virus Disease at the Late Outbreak Stage in Sierra Leone: Clinical, Virological, Immunological, and Evolutionary Analyses.

Ebolaviruscomparative Genomics

Genetic Diversity and Evolutionary Dynamics of Ebola Virus in Sierra Leone

Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity

Ebola Virus Disease: General Characteristics, Thoughts, and Perspectives.

The Ebola outbreak, 2013–2016: old lessons for new epidemics

The Lifecycle of the Ebola Virus in Host Cells.

The Western Africa Ebola Virus Disease Epidemic Exhibits Both Global Exponential and Local Polynomial Growth Rates

Ebolavirus evolution and emergence are associated with land use change

Identifying spatiotemporal dynamics of Ebola in Sierra Leone using virus genomes

A Glycoprotein Mutation That Emerged during the 2013-2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane Fusion

Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks